Fatigue After Acquired Brain Injury Impacts Health-related Quality of Life: an Exploratory Cohort Study
Affiliations
This study aimed to identify the consequences of fatigue, fatigability, cognitive and executive functioning, and emotional state on health-related quality of life (HRQoL) in a clinical group of outpatients after acquired brain injury (ABI). This cross-sectional retrospective study included assessing outpatients at a rehabilitation clinic with WAIS-III working memory and coding subtests, and self-rating scales (Fatigue Impact Scale, Dysexecutive Questionnaire, Hospital Anxiety and Depression Scale, and the dimension of health-related quality of life from EQ-5D-3L). The predictive variables were investigated using a binary logistic regression with HRQoL as the dependent variable. Descriptive statistics and correlations were analyzed. Participants reported a lower than average HRQoL (95%), fatigue (90%), and executive dysfunction (75%). Fatigue had a significant impact and explained 20-33% of the variance in HRQoL with a moderate significance on depression (p = 0.579) and executive dysfunction (p = 0.555). Cognitive and executive function and emotional state showed no association with HRQoL. A lower HRQoL, as well as fatigue and cognitive and executive dysfunctions, are common after ABI, with fatigue is a partial explanation of a lower HRQoL.
MacDonald E, Pellerine L, Miller K, Frayne R, OBrien M Front Rehabil Sci. 2024; 5:1427446.
PMID: 39713263 PMC: 11659261. DOI: 10.3389/fresc.2024.1427446.
Nordstrom E, Vestberg S, Evald L, Mion M, Segerstrom M, Ullen S Crit Care. 2023; 27(1):328.
PMID: 37633944 PMC: 10463667. DOI: 10.1186/s13054-023-04617-0.
Mann G, Troeung L, Singh K, Reddell C, Martini A Neurol Sci. 2023; 44(7):2401-2411.
PMID: 36780031 PMC: 10257595. DOI: 10.1007/s10072-023-06645-8.
The Impact of Cancer-Related Fatigue on HRQOL in Survivors of Childhood Cancer: A DCCSS LATER Study.
Penson A, Walraven I, Bronkhorst E, Maurice-Stam H, Grootenhuis M, van der Heiden-van der Loo M Cancers (Basel). 2022; 14(12).
PMID: 35740518 PMC: 9221067. DOI: 10.3390/cancers14122851.